Valuation: Kenvue Inc.

Capitalization 3.47TCr 2.94TCr 2.69TCr 2.55TCr 4.74TCr 3,14700Cr 4.96TCr 31TCr 12TCr 1,51500Cr 13TCr 13TCr 5,45400Cr P/E ratio 2025 *
23.8x
P/E ratio 2026 * 19.1x
Enterprise value 4.24TCr 3.59TCr 3.29TCr 3.11TCr 5.78TCr 3,84000Cr 6.05TCr 38TCr 15TCr 1,84900Cr 16TCr 16TCr 6,65500Cr EV / Sales 2025 *
2.82x
EV / Sales 2026 * 2.73x
Free-Float
99.66%
Yield 2025 *
4.54%
Yield 2026 * 4.64%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.33%
1 week+4.20%
Current month+4.20%
1 month+6.71%
3 months+7.41%
6 months-15.04%
Current year+5.10%
More quotes
1 week 17.25
Extreme 17.25
18.22
1 month 16.84
Extreme 16.84
18.22
Current year 16.56
Extreme 16.555
18.22
1 year 14.02
Extreme 14.02
25.17
3 years 14.02
Extreme 14.02
27.8
5 years 14.02
Extreme 14.02
27.8
10 years 14.02
Extreme 14.02
27.8
More quotes
Manager TitleAgeSince
Chief Executive Officer 59 14/07/2025
Director of Finance/CFO 57 12/05/2025
Chief Tech/Sci/R&D Officer 57 -
Director TitleAgeSince
Chairman 70 01/05/2023
Director/Board Member 66 04/05/2023
Director/Board Member 58 08/05/2023
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+0.33%+4.20%-10.16% - 3.47TCr
+0.35%+4.88%-5.24%+14.87% 37TCr
-0.65%+4.57%-1.44%+12.92% 16TCr
-0.50%+4.56%+8.82%+28.69% 7.61TCr
+0.45%+3.30%+3.11%-5.86% 6.92TCr
+2.91%-13.71%+52.96%-61.62% 3.6TCr
-0.31%+4.57%-19.69%-6.62% 2.67TCr
-0.88%+5.66%-1.53%+2.33% 2.11TCr
+1.35%+2.36%+9.75%+27.30% 1.33TCr
+1.20%+3.09%-2.59%-3.53% 995.14Cr
Average +0.12%+1.99%+3.40%+0.94% 8.15TCr
Weighted average by Cap. -0.39%+3.90%-0.22%+9.36%
See all sector performances

Financials

2025 *2026 *
Net sales 1.5TCr 1.27TCr 1.17TCr 1.1TCr 2.05TCr 1,36100Cr 2.14TCr 14TCr 5.36TCr 66TCr 5.63TCr 5.52TCr 2,35900Cr 1.54TCr 1.31TCr 1.2TCr 1.13TCr 2.11TCr 1,39900Cr 2.2TCr 14TCr 5.51TCr 67TCr 5.79TCr 5.67TCr 2,42400Cr
Net income 148.83Cr 125.98Cr 115.46Cr 109.36Cr 203.06Cr 13TCr 212.3Cr 1.34TCr 531.2Cr 6.49TCr 558.14Cr 546.65Cr 23TCr 185.92Cr 157.38Cr 144.24Cr 136.61Cr 253.67Cr 17TCr 265.21Cr 1.68TCr 663.6Cr 8.11TCr 697.25Cr 682.9Cr 29TCr
Net Debt 765.06Cr 647.62Cr 593.56Cr 562.16Cr 1.04TCr 69TCr 1.09TCr 6.9TCr 2.73TCr 33TCr 2.87TCr 2.81TCr 1,20100Cr 734.52Cr 621.77Cr 569.86Cr 539.72Cr 1TCr 67TCr 1.05TCr 6.62TCr 2.62TCr 32TCr 2.75TCr 2.7TCr 1,15300Cr
More financial data * Estimated data
Logo Kenvue Inc.
Kenvue Inc. is one of the world leaders in the design, manufacture and marketing of consumer healthcare products. The group offers products for health, beauty, baby care, oral care, skin care and more. Net sales break down by family of products as follows: - self care products (42,3%): for the treatment of coughs, colds, allergies, pain, indigestion, constipation, etc. (brands Zyrtec, Benadryl, Zarbee's, Frenadol, Codral, Reactine, Tylenol, Motrin, Calpol, Nicorette, Imodium, Pepcid, Microlax, Daktarin, etc.); - personal care products (30.3%): primarily oral care, baby care, women's health and wound care products (Listerine, Desitin, Carefree, Stayfree, Band-Aid, Neosporin brands, etc.); - beauty and skin care products (27.4%): hair care products, sun protection products, face and body care products, etc. (Neutrogena, Aveeno, Clean&Clear, Lubriderm, Johnsons, Neostrata, OGX, Rogaine brands, etc.). Product marketing is assured through direct sales, distributors and the Internet. Net sales are distributed geographically as follows: North America (49%), Europe-Middle East-Africa (23%), Asia-Pacific (19.3%) and Latin America (8.7%).
Employees
22,000
More about the company
Date Price Change Volume
06/26/06 18.13 $ +0.33% 6,34,58,954
05/26/05 18.07 $ +0.33% 10,88,38,661
04/26/04 18.01 $ +2.39% 9,42,49,277
03/26/03 17.59 $ +1.21% 4,58,11,865
02/26/02 17.38 $ -0.11% 2,49,77,463

Delayed Quote Nyse, February 07, 2026 at 02:30 am IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
AA
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
14
Last Close Price
18.13USD
Average target price
18.92USD
Spread / Average Target
+4.34%
Consensus

Quarterly revenue - Rate of surprise